Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

Even though obsessive compulsive disorder (OCD) is one of the ten most disabling
diseases according to the WHO, only 30–40% of patients suffering from OCD seek …

Classic psychedelics, such as psilocybin, act on the brain's serotonin system and produce
striking psychological effects. Early work in the 1950s and 1960s and more recent controlled …

Obsessive-compulsive disorder (OCD) is a pervasive disabling disorder that may overlap
with other psychiatric conditions, including anorexia nervosa. Recent guidelines recommend …

Obsessive-compulsive disorder (OCD) is a chronic and debilitating illness that has been
considered a polygenic and multifactorial disorder, challenging effective therapeutic …

The intricate neural pathways involved in obsessive-compulsive disorder (OCD) affect areas
of our brain that control executive functioning, organization, and planning. OCD is a chronic …

Abstract Background and aim Although Repetitive Transcranial Magnetic Stimulation (rTMS)
is a promising new noninvasive brain stimulation therapy, its underlying mechanisms of …

Background Twenty years after the first use of Deep Brain Stimulation (DBS) in obsessive-
compulsive disorder (OCD), our knowledge of the long-term effects of this therapeutic option …

Obsessive-compulsive disorder (OCD) affects approximately one person in 40 and causes
substantial suffering. Evidence-based treatments can benefit many; however, optimal …

Obsessive-compulsive disorder (OCD) is a chronic mental disease that affects
approximately 2% of the population. Obsessions and compulsions are troublesome for …